Due to the difficult nature of collecting tumor tissues from CDDP‐resistant seminoma patients, it was challenging to directly compare the levels of H19, miRNA‐106b‐5p, and TDRG1 between primary tumors and their CDDP‐resistant counterparts. The gene discussed is H19; the disease is seminoma.